Market Access and Evidence Generation Strategies

We provide expert input and guidance to companies wishing to develop innovative pricing and market access strategies

market access strategy
from industry experts

The development of a market access strategy needs to start early with a focus on how best to design the clinical trial programme to meet the evidence needs of regulators, payers, prescribers, and patients whilst ensuring a competitively differentiated profile. Patient-reported outcomes are our passion, so we are happy to advise companies on instrument selection and analytic strategies. Due to the rapidly evolving landscape, real-world evidence plays a critical role in addressing research questions that a clinical trial cannot. We have strong expertise in real-world evidence generation strategies to inform health economic models, support single-arm studies and inform knowledge and understanding of treatment pathways.

We also have experience of developing outcomes-based payment schemes for cell & gene therapies.

$375bnexpected spending total on cancer medicines by 2027

5%global increase number of treated patients over the past five years

2,000oncology products currently under development

a consultancy you can trust

we are  
industry experts

we are
dedicated

we are
patient-centric

a wealth of life science
knowledge and expertise

Oncology Access Solutions Ltd is led and founded by Dr Clare Hague – a highly experienced health economist and health services researcher with a strong industry and academic background.

With over 18 years of industry experience with large, mid-sized and start-up biotech companies, we Clare is a seasoned and knowledgeable independent consultant able to provide a discreet and dedicated service.

Learn more